全文获取类型
收费全文 | 72717篇 |
免费 | 6978篇 |
国内免费 | 2475篇 |
专业分类
耳鼻咽喉 | 158篇 |
儿科学 | 793篇 |
妇产科学 | 2030篇 |
基础医学 | 3525篇 |
口腔科学 | 579篇 |
临床医学 | 6689篇 |
内科学 | 7692篇 |
皮肤病学 | 1141篇 |
神经病学 | 2265篇 |
特种医学 | 726篇 |
外国民族医学 | 7篇 |
外科学 | 2609篇 |
综合类 | 9042篇 |
现状与发展 | 9篇 |
一般理论 | 4篇 |
预防医学 | 4984篇 |
眼科学 | 722篇 |
药学 | 32077篇 |
47篇 | |
中国医学 | 3112篇 |
肿瘤学 | 3959篇 |
出版年
2024年 | 199篇 |
2023年 | 1189篇 |
2022年 | 1793篇 |
2021年 | 2626篇 |
2020年 | 2655篇 |
2019年 | 2662篇 |
2018年 | 2754篇 |
2017年 | 2999篇 |
2016年 | 2852篇 |
2015年 | 2905篇 |
2014年 | 4828篇 |
2013年 | 8344篇 |
2012年 | 4689篇 |
2011年 | 4932篇 |
2010年 | 3850篇 |
2009年 | 3633篇 |
2008年 | 3380篇 |
2007年 | 3343篇 |
2006年 | 3000篇 |
2005年 | 2692篇 |
2004年 | 2311篇 |
2003年 | 2023篇 |
2002年 | 1555篇 |
2001年 | 1447篇 |
2000年 | 1163篇 |
1999年 | 977篇 |
1998年 | 866篇 |
1997年 | 801篇 |
1996年 | 653篇 |
1995年 | 615篇 |
1994年 | 525篇 |
1993年 | 459篇 |
1992年 | 513篇 |
1991年 | 416篇 |
1990年 | 345篇 |
1989年 | 279篇 |
1988年 | 265篇 |
1987年 | 252篇 |
1986年 | 211篇 |
1985年 | 222篇 |
1984年 | 175篇 |
1983年 | 143篇 |
1982年 | 118篇 |
1981年 | 92篇 |
1980年 | 64篇 |
1979年 | 64篇 |
1978年 | 72篇 |
1977年 | 49篇 |
1976年 | 48篇 |
1975年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
Mark Beuger md Anthony Tommasello ms Robert Schwartz md Mary Clinton pharmd 《Journal of substance abuse treatment》1998,15(6):15-593
Forty-eight consecutive applicants and 30 known clonidine-abusing methadone patients at three methadone treatment programs were surveyed regarding their use of clonidine. Two distinct patterns of clonidine use emerged. Of 22 applicants who took clonidine illicitly, 15 used it primarily to decrease opioid withdrawal, as well as for its sedating effect. Applicants mostly obtained it from physicians, used an average dose of 0.37 mg at a time, and about one third believed clonidine to be addictive. In contrast, clonidine-using patients took clonidine primarily for its psychoactive effects, including the interaction with methadone, in addition to decreasing opioid withdrawal. Patients obtained clonidine frequently on the street and from family or friends, but less from physicians. The average reported dose for patients was 0.6 mg. The vast majority of these patients felt clonidine was addictive. Our findings, when coupled with the risk inherent in clonidine overdose, suggest that further research into the identification and treatment of clonidine abuse among methadone patients is warranted. 相似文献
152.
Walter G. Sannita Luisa Lopez Lino Maggi Guido Rosadini 《Documenta ophthalmologica. Advances in ophthalmology》1988,70(1):89-96
L-acetylcarnitine is a compound with cholinergic properties and putative action on the visual system and the glucose metabolism. Ten healthy, emmertropic volunteers (age range: 21 to 28 years) were studied. Each subject was administered 5, 10, and 30 mg/kg acute intravenous doses of L-acetylcarnitine and matching placebo. Retinal oscillatory potentials to full-field flash stimulation were recorded before and 30, 60, and 120 min after administration. A systematic reduction of the implicit time of the P2 and N2 oscillatory potential components was observed after administration of the 10 and 30 mg/kg doses: significant changes were not evident at the 5 mg dose or after placebo. The latency reduction was significantly correlated with the postdrug increment of the L-acetylcarnitine plasma concentration. No other systematic modification in latency of amplitude was observed.The results were presented in part at the XXV I.S.C.E.V. Symposium, Sarasota (Florida), April 26–30, 1987. 相似文献
153.
本文阐述了奥美拉唑(Omeprazole)治疗急性上消化道大出血80例与法莫替丁(Famotidine)治疗上消化道大出血50例比较,前者有效率明显高于后者。提示奥美拉唑治疗急性上消化道大出血效果好,无副作用,减少了手术率、死亡率,是一种有效的止血药物。 相似文献
154.
Bronwyn A. Kingwell Lisa Krause Stevo Julius 《Clinical and experimental pharmacology & physiology》1994,21(1):31-39
1. Left ventricular (LV) hypertrophy has been implicated in the reduction of baroreflex sensitivity present in hypertension. The aim of the current study was to investigate the mean arterial pressure-heart rate reflex (MAP-HR) in a model which induced left ventricular hypertrophy but no sustained blood pressure elevation. 2. Five mongrel dogs were exposed to transient blood pressure elevation of between 20 and 30 mmHg, through hindlimb compression using a pneumatic pressure suit, for 7 h per day, 6 days per week for 6 weeks. Resting blood pressure was not altered by the 6 week hindlimb compression intervention. 3. Echocardiographically determined LV mass (mean ± s.e.m.) was 116.0 ± 7.4 g prior to hindlimb compression (baseline) and elevated to 125.4 ± 8.1 g (P= 0.003) after 6 weeks of compression. A reduction in the early (E) to late (A) transmitral diastolic flow ratio (E/A) from 1.80 ± 0.06 at baseline to 1.54 ± 0.09 (P = 0.037) after the 6 week intervention suggested that cardiac compliance was reduced. 4. The maximum gain of the MAP-HR reflex, studied using the ‘steady-state’ drug technique, when blood pressure was normal, showed a trend for reduction from 3.85 ± 0.43 beats/min per mmHg at baseline to 3.10 ± 0.45 beats/min per mmHg (P= 0.067) after 6 weeks of compression. This gain reduction became significant after β-adrenoceptor blockade with propranolol (3.13 ± 0.55 vs 2.32 ± 0.25 beats/min per mmHg; P= 0.039). Covariant analysis showed a significant inverse correlation between LV mass and maximum gain (r= 0.96; P<0.001) during the 6 week compression period. 5. The MAP-HR reflex changes in this model mimic those present in hypertension and implicate cardiac hypertrophy as one possible mediator. 相似文献
155.
B. Lacarelle O. Blin C. Audebert P. Auquier H. Karsenty F. Horriere A. Durand 《European journal of clinical pharmacology》1994,46(5):477-478
The kinetics of a single i. v. dose of theophylline given either alone or with flumequine was studied in eight healthy volunteers. No statistically significant differences were observed in the pharmacokinetic parameters of theophylline (volume of distribution, elimination half-life, AUC, plasma clearance) following the two treatments.Pretreatment for 5 days with oral flumequine (400 mg, three times daily) had no significant effect on the disposition of a single i. v. dose of theophylline in healthy volunteers. 相似文献
156.
G. Miremont F. Haramburu B. Bégaud J. C. Péré J. Dangoumau 《European journal of clinical pharmacology》1994,46(4):285-289
Since spontaneous reporting of adverse drug reactions depends on the physician's opinion of the relationship between the drug and the adverse event, we compared physicians' opinions with the scores obtained by the causality assessment method used in France. During a 2 month period, all physicians who reported adverse drug reactions (ADRs) to our pharmacovigilance centre expressed their opinions on the causal link by means of visual analogue scales. ADR reports were then assessed with the French causality assessment method by a clinical pharmacologist who was blind to physicians' opinions.The assessment by both physicians and the standardized method was performed for 75 ADR cases involving 120 drugs. Physicians used a wide range of assessments, with a preponderance of extreme scores, resulting in a U-shaped distribution, while the standardized method gave generally low scores. Scores given by physicians were very high (causality considered very likely or likely) in 60% of cases and very low (causality considered unlikely or dubious/possible) in 32% of cases. Scores obtained using the causality assessment method were low (causality dubious/possible) in 89% of cases and causality considered likely in only 11 cases, essentially in cases with positive rechallenge. Complete agreement occurred in only 6% of cases. Adding complete agreement and minor discrepancies raised the percentage to 49%. 相似文献
157.
158.
靳培英 《中国新药与临床杂志》1992,(5)
443例(男225例,女218例;年龄36±14a)皮肤病患者,其中150例(扁平疣52例、寻常疣55例、银屑病43例)外用含1.8%十二烷氮(艹卓)酮的1%氟尿嘧啶(5-FU)凝胶作为治疗组,148例外用1%5-FU凝胶及145例外用2.5%5-FU霜作为2个对照组。经双盲对照临床试验,结果表明含1.8%十二烷氮(艹卓)酮的1%5-FU凝胶的疗效明显优于2个对照组(P<0.01及P<0.005)。证明氮(艹卓)酮对5-FU确有渗透促进作用。 相似文献
159.
E M Mathus-Vliegen K van de Voorde A M Kok A M Res 《Journal of internal medicine》1992,232(2):119-127
Dexenfluramine, an effective and safe serotoninergic drug with anorectic and possible food-selection-tuning properties, was investigated in a placebo-controlled study of 1 year's duration in severe and refractory obesity. The aim of the study was to assess weight loss, and changes in cardiovascular risk factors, food intake and eating behaviour. Dexfenfluramine- and placebo-treated patients achieved a similar weight loss (greater than 10% of initial weight, by 39.5 and 30.0%, greater than 20% of initial overweight by 42.1% and 32.5% and greater than 10 kg by 41.4 and 33.3%, respectively, of the initial cohorts). Furthermore, the decreases in weight (10.7 vs. 8.0 kg), in body mass index (3.9 vs. 2.9 kg m2) and in waist/hip ratio (0.04 vs. 0.02) were not significantly different. After discontinuation of the drug, the increase in weight (2.8 vs. 1.0 kg) was significantly higher in the dexfenfluramine-treated group. Except for a borderline better effect on glucose of dexfenfluramine, both groups showed similar beneficial changes in food intake and cardiovascular risk factors. Eating behaviour in response to emotional and external stimuli was comparable in the two groups, but placebo-treated patients had to restrain their eating more in order to achieve the same weight loss. Notwithstanding the fact that weight losses and an associated amelioration of health-risk factors were of similar magnitude in dexfenfluramine- and placebo-treated patients, dexfenfluramine might have a useful role in promoting a less stressed adherence to prolonged restriction of energy intake in the severe and refractory obese subject. 相似文献
160.